Simcere News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Simcere. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Simcere Today - Breaking & Trending Today

First Prescription for COSELA® (trilaciclib) Issued in China

/PRNewswire/ Simcere Pharmaceutical Group Limited (2096.HK) ("Simcere"), an innovative global biopharmaceutical company, and G1 Therapeutics, Inc., (Nasdaq:. ....

United States , Tang Renhong , Jack Bailey , Simcere Pharmaceutical Group , Prnewswire Simcere Pharmaceutical Group , Therapeutics Inc , Research Triangle Park , National Comprehensive Cancer Network , Chinese Society Of Clinical Oncology , Jilin Cancer Hospital , Pharmaceutical Group Limited , Chief Executive Officer , Executive Director , Comprehensive Cancer , Clinical Practice Guidelines , Clinical Oncology , New Drug Application , Lung Cancer ,

Idorsia Pharmaceuticals Ltd: Idorsia and Simcere enter into a licensing agreement for daridorexant in China

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland & Nanjing, China - November 16, 2022 Idorsia Ltd (SIX: IDIA, "Idorsia"), specialized in the discovery, development and ....

United States , Hong Kong , United Kingdom , Switzerland General , Great Britain , Andrewc Weiss , Jinsheng Ren , Jean Paul Clozel , J Clin Pharmacol , Idorsia Ltd , American Psychiatric Association , Head Of Investor Relations Corporate Communications , Simcere Pharmaceutical Group , European Commission Decision Reliance Procedure , European Commission , Drug Administration , Simcere Pharmaceutical Group Ltd , Swiss Exchange , Regulatory Agency , National Medical Products Administration , Idorsia Pharmaceuticals Ltd , Health Canada , Central Nervous System , Greater China , Mainland China , Paul Clozel ,

Simcere Receives FDA Clearance of Investigational New Drug Application (IND) for Bi-functional Fusion Protein, SIM0237

/PRNewswire/ Simcere Pharmaceutical Group (2096.HK), an innovative global pharmaceutical company, today announced that the U.S. Food and Drug Administration. ....

United States , Bijoyesh Mookerjee , Prnewswire Simcere Pharmaceutical Group , Simcere Pharmaceutical Group , National Medical Products Administration On , Drug Administration , Pharmaceutical Group , National Medical Products Administration , Chief Medical Officer , Pharmaceutical Group Limited ,

Simcere agree license deal of $492M USD with Almirall

Almirall granted exclusive rights to commercialise SIM0278 for all indications outside the Greater China region, (Mainland China, Hong Kong, Macau and Taiwan) ....

Hong Kong , United States , Comunidad Autonoma De Cataluna , Renhong Tang , Karl Ziegelbauer , Innovative Pharmaceutical Enterprises , Simcere Pharmaceutical Group , Innovative Drug Development , Manufacturing Enterprises Of China , Spanish Stock Exchange , Key Laboratory Of Translational Medicine , Greater China , Mainland China , Pharmaceutical Group , Chief Scientific , Pharmaceutical Group Limited , State Key Laboratory , Translational Medicine , Pharmaceutical Enterprises , Manufacturing Enterprises , Noble Purpose ,

SIMCERE PHARMA (HK.2096) Novel Inhibitor of COVID-19 3CLpro SIM0417 Received a Second Clinical Trial Approval in China

/PRNewswire/ SIMCERE PHARMA (HK.2096) announced that SIM0417, a candidate drug against SARS-Cov-2, for which the Company holds license from Shanghai. ....

Clinical Trial Approval , Shandong Provincial Qianfoshan ,